Venky Soundararajan (via Medium)

A for aug­ment­ed: Cam­bridge AI com­pa­ny out to cap­ture bio­med­ical knowl­edge gets $60M from Mayo, Sil­i­con Val­ley VC

The Mayo Clin­ic is join­ing hands with a Sil­i­con Val­ley VC firm to in­ject $60 mil­lion in­to nfer­ence, a Cam­bridge, MA-based play­er in the gold rush to cap­i­tal­ize on bio­phar­ma’s grow­ing in­ter­est — and urge — to ac­cel­er­ate drug dis­cov­ery and de­vel­op­ment us­ing the lat­est ma­chine learn­ing tools.

While nfer­ence os­ten­si­bly be­longs to a gen­er­a­tion of soft­ware star­tups that cropped up around 2013, it doesn’t see it­self as part of the AI main­stream, founder and CSO Venky Soundarara­jan tells End­points News. That’s why the A in their AI stands for aug­ment­ed, not ar­ti­fi­cial.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.